A team of UCLA Health researchers has been awarded a National Institutes of Health (NIH) grant for a five-year study to determine whether school-based health centers (SBHCs) can improve health and academic outcomes for students experiencing chronic absenteeism.
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that Manuka honey could potentially be an alternative, natural option for breast cancer prevention and treatment— particularly for estrogen receptor (ER)-positive breast cancer, the most common subtype of breast cancer that accounts for about 70–80% of all breast cancer cases.
Accreditation includes a rigorous evaluation and review of every aspect of cancer care from prevention and early diagnosis to treatment, rehabilitation, and survivorship. By meeting these standards, the cancer center ensures that patients receive the highest level of care and support throughout their cancer journey.
The Brain & Behavior Research Foundation recognized Dr. Edgcomb for her research into the development of set rules to clearly identify children and adolescents with suicide-related symptoms using electronic health record data.
As students begin a new school year, school district officials across California are considering or establishing cellphone-use restrictions on campus. Their reasoning? Increased screen time, along with prolonged social media use, may disrupt the learning environment, stunt social development and harm students’ mental health, they say.
In a new study, a molecule identified and synthesized by UCLA Health researchers was shown to restore cognitive functions in mice with symptoms of Alzheimer’s disease by effectively jumpstarting the brain's memory circuitry.
Immunotherapy pioneer Dr. Antoni Ribas, professor of medicine at the David Geffen School of Medicine at UCLA and director of the tumor immunology program at the UCLA Health Jonsson Comprehensive Cancer Center, has been inducted into the 2024 Class of Fellows of the Academy of Immuno-Oncology by the Society for Immunotherapy of Cancer.
Newirth beat the odds thanks to a novel cancer vaccine developed by UCLA neurosurgeon Linda Liau, MD, PhD. And now, he’s doing everything in his power to support cutting-edge cancer research and provide extra support to individuals going through cancer treatment.
UCLA Health researchers, in collaboration with researchers from the Republic of Ireland and Northern Ireland, have received $9.5 million award from the National Institutes of Health (NIH) with support from European funding agencies — The Science Foundation Ireland (SFI) and the Public Health Agency Health & Social Care (HSC) — to study the effects of polyphenols on cognitive health and the brain-gut microbiome system.
In an effort to combat one of the most lethal forms of pediatric brain cancer, researchers at the UCLA Health Jonsson Comprehensive Cancer Center are launching a first-of-its-kind clinical trial to evaluate the safety and effectiveness of a cancer vaccine targeting H3 G34-mutant diffuse hemispheric glioma, a highly aggressive brain tumor that is typically found in adolescents and young adults.
Executive Chef Sonny Sweetman was diagnosed with uveal melanoma, a rare type of cancer that occurs in the eye. The melanoma is derived from the melanocytes in the uvea, accounting for only about 5% of all cases of melanoma in the United States.
A new paper surveying advances in diabetes pathogenesis and treatment explores the complex factors contributing to the onset and progression of the disease, suggesting that an understanding of these dynamics is key to developing targeted interventions to reduce the risk of developing diabetes and managing its complications.
Researchers at UCLA Health uncovered new information about the role inflammation plays in mitigating liver fibrosis, which is associated with metabolic-associated fatty liver disease (MAFLD), one of the most common diseases in the world affecting up to 40 percent of U.S. adults.
The award, $300,000 over the next three years, supports their efforts in gaining a deeper understanding of the microenvironment's role in shaping human glioblastoma, an aggressive type of brain cancer that is fast growing and difficult to treat.
The study, published in Urology Practice, reveals that while there were clear differences in treatment preferences among the profiles, these preference profiles did not significantly influence the patients' final treatment choices.
New research led by UCLA Health has found that specific genes may be related to the trajectory of recovery for stroke survivors, providing doctors insights useful for developing targeted therapies.
Research from UCLA Fielding School of Public Health’s Randall Kuhn and colleagues at UCLA and USC shows the health risk for people experiencing homelessness goes beyond challenges inherent to living without shelter.
Rates of subsequent myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) following an acute illness were roughly the same between people whose acute illness was due to COVID-19 and those who did not have COVID-19.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
